Suppressive effect of FK-506, a novel immunosuppressant, against MPTP-induced dopamine depletion in the striatum of young C57BL/6 mice

J Neuroimmunol. 1994 Mar;50(2):221-4. doi: 10.1016/0165-5728(94)90049-3.

Abstract

Systemic injection of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is known to damage the dopaminergic nigrostriatal system in C57BL/6 mice. We have investigated the effects of immunosuppressants, FK-506 and cyclosporin A (CsA), on MPTP-induced dopamine (DA) depletion in the striatum of young C57BL/6 mice. 10 days after MPTP treatment (25 mg/kg i.p. given daily, 5 days), DA in the striatum was depleted by 80%. However, pretreatment with FK-506, a novel immunosuppressant, significantly protected MPTP-induced DA depletion in the striatum, but FK-506 itself did not affect the DA content. CsA, another immunosuppressant, also protected MPTP-induced DA depletion. From these results can be seen that immunosuppressants seem to inhibit MPTP neurotoxicity toward nigrostriatal dopaminergic neurons of young C57BL/6 mice.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / pharmacology*
  • Animals
  • Brain / metabolism
  • Corpus Striatum / metabolism*
  • Cyclosporine / pharmacology
  • Dopamine / deficiency*
  • Immunosuppressive Agents / pharmacology*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Norepinephrine / metabolism
  • Picibanil / pharmacology
  • Serotonin / metabolism
  • Tacrolimus / pharmacology*
  • Tissue Distribution

Substances

  • Immunosuppressive Agents
  • Serotonin
  • Picibanil
  • Cyclosporine
  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
  • Dopamine
  • Tacrolimus
  • Norepinephrine